Health Trials

Pheochromocytomas

2

Review clinical trials related to Pheochromocytomas. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT)

This multicenter retrospective Italian study evaluates the efficacy and safety of PRRT in patients with advanced, unresectable or metastatic pheochromocytomas and paragangliomas (PPGL). Data from \~210 patients treated between 2000 and 2024 will be analyzed. The primary endpoint is disease control rate (DCR). Secondary endpoints include progression-free survival (PFS), overall survival (OS), and prognostic factors.

Participants needed: 210
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Azienda USL Reggio Emilia - IRCCSUpdated: Apr 24, 2026Locations: 10
Eligibility criteria

Documented diagnosis of pheochromocytoma or paraganglioma (PPGL) (sporadic or he... [+4]

Patients who did not receive at least one cycle of peptide receptor radionuclide...

Read more
Status: Recruiting

HTL0039732 in Participants With Advanced Solid Tumours

The purpose of this trial is to evaluate a new drug, HTL0039732, that will be administered on its own (as a monotherapy) and in combination with atezolizumab or with other approved anti-cancer therapies, in participants with advanced solid tumours.

Participants needed: 150
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Cancer Research UKUpdated: Jun 8, 2025Locations: 5
Eligibility criteria

Written (signed and dated) informed consent and capable of co-operating with inv... [+22]

Radiotherapy (except for palliative reasons), chemotherapy, non chemotherapy sys... [+22]

Read more